Kathleen Sebelius

HUMA

Kathleen Sebelius serves as director at Humacyte, Inc. (HUMA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$116.0K

Total Sells

1 trades

$28.0K

Net Position

Net Buyer

$88.0K

Companies Traded

HUMA

Active Period

Sep 2024 – May 2026

3 total trades

Most Recent

Buy HUMA

May 20, 2026 · $50.0K

Kathleen Sebelius's Insider Trading at Humacyte, Inc. (HUMA)

Buys

2 · $116.0K

Sells

1 · $28.0K

Total Shares Bought

106,818

Total Shares Sold

5,182

HUMA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 20, 2026	Buy	56,818	$0.88	$50.0K	148,025
Apr 8, 2025	Buy	50,000	$1.32	$66.0K	0
Sep 11, 2024	Sell	5,182	$5.40	$28.0K	41,207

Related Insiders

Keith Anthony Jones

director

HUMABuy · Sep 15, 2026

Michael T. Constantino

director

HUMABuy · May 20, 2026

Shamik J Parikh

officer: Chief Medical Officer

HUMASell · May 20, 2026

Dale A. Sander

officer: CFO and Chief Corp. Dev. Off

HUMASell · May 20, 2026

Explore More Insider Trading Data

HUMA Insider Trading Activity

View all insider trades at Humacyte, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity